Pretreatment clinical prognostic factors in patients with stage IV non-small cell lung cancer (NSCLC) treated with chemotherapy
作者： Branislav Jeremic , Biljana Milicic , Aleksandar Dagovic , Jasna Aleksandrovic , Nebojsa Nikolic
DOI: 10.1007/S00432-002-0408-4
关键词: Clinical trial 、 Hematology 、 Survival analysis 、 Chemotherapy 、 Internal medicine 、 Oncology 、 Metastasis 、 Medicine 、 Pathology 、 Carcinoma 、 Respiratory disease 、 Prospective cohort study
摘要: Purpose. We investigated the influence of potential pre-treatment clinical prognostic factors in stage IV non-small cell lung cancer (NSCLC).
springer.com
sci-hub.se 参考文章(46)
Lee Kl, Harrell Fe, Matchar Db, Reichert Ta, Regression models for prognostic prediction: advantages, problems, and suggested solutions Cancer treatment reports. ,vol. 69, pp. 1071- 1077 ,(1985)
Jens Benn Sorensen, Prognostic Factors in Inoperable Adenocarcinoma of the Lung: A Multivariate Regression Analysis of 259 Patients Cancer Research. ,vol. 49, pp. 5748- 5754 ,(1989)
D M Finkelstein, D S Ettinger, J C Ruckdeschel, Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study. Journal of Clinical Oncology. ,vol. 4, pp. 702- 709 ,(1986) , 10.1200/JCO.1986.4.5.702
J P O'Connell, M G Kris, R J Gralla, S Groshen, A Trust, J J Fiore, D P Kelsen, R T Heelan, R B Golbey, Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy. Journal of Clinical Oncology. ,vol. 4, pp. 1604- 1614 ,(1986) , 10.1200/JCO.1986.4.11.1604
E Glatstein, R W Makuch, Illusion and reality: practical pitfalls in interpreting clinical trials. Journal of Clinical Oncology. ,vol. 2, pp. 488- 497 ,(1984) , 10.1200/JCO.1984.2.5.488
A J Wozniak, J J Crowley, S P Balcerzak, G R Weiss, C H Spiridonidis, L H Baker, K S Albain, K Kelly, S A Taylor, D R Gandara, R B Livingston, Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: A Southwest Oncology Group study Journal of Clinical Oncology. ,vol. 16, pp. 2459- 2465 ,(1998) , 10.1200/JCO.1998.16.7.2459
A.B. Sandler, J. Nemunaitis, C. Denham, J. von Pawel, Y. Cormier, U. Gatzemeier, K. Mattson, Ch. Manegold, M.C. Palmer, A. Gregor, B. Nguyen, C. Niyikiza, L.H. Einhorn, Phase III Trial of Gemcitabine Plus Cisplatin Versus Cisplatin Alone in Patients With Locally Advanced or Metastatic Non–Small-Cell Lung Cancer Journal of Clinical Oncology. ,vol. 18, pp. 122- 122 ,(2000) , 10.1200/JCO.2000.18.1.122
Diane Fairclough, David Cella, John Kugler, Eric Rowinsky, Michael Jiroutek, David Johnson, Philip Bonomi, KyungMann Kim, Comparison of Survival and Quality of Life in Advanced Non–Small-Cell Lung Cancer Patients Treated With Two Dose Levels of Paclitaxel Combined With Cisplatin Versus Etoposide With Cisplatin: Results of an Eastern Cooperative Oncology Group Trial Journal of Clinical Oncology. ,vol. 18, pp. 623- 631 ,(2000) , 10.1200/JCO.2000.18.3.623
Ulrich Gatzemeier, Joachim von Pawel, Maya Gottfried, G.P. M. ten Velde, Karin Mattson, Filipo DeMarinis, Peter Harper, Franco Salvati, Gilles Robinet, Antonio Lucenti, Jan Bogaerts, Gilles Gallant, Phase III comparative study of high-dose cisplatin versus a combination of paclitaxel and cisplatin in patients with advanced non-small-cell lung cancer. Journal of Clinical Oncology. ,vol. 18, pp. 3390- 3399 ,(2000) , 10.1200/JCO.2000.18.19.3390
M Paesmans, J P Sculier, P Libert, G Bureau, G Dabouis, J Thiriaux, J Michel, O Van Cutsem, R Sergysels, P Mommen, Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party. Journal of Clinical Oncology. ,vol. 13, pp. 1221- 1230 ,(1995) , 10.1200/JCO.1995.13.5.1221